Search
Search Results
-
Survivorship care for patients curatively treated for Hodgkin’s and non-Hodgkin’s lymphoma: a sco** review
PurposeWe undertook a sco** review of the literature to synthesize what is known about lymphoma survivorship and develop a comprehensive set of...
-
Clinical Profile and Outcome of Adult Classical Hodgkin’s Lymphoma: Real World Single Centre Experience
Hodgkin’s lymphoma treatment outcomes have been the true success story of modern medicine. Various data from western as well as Indian studies are...
-
-
Long-term cardiac effects of modern treatment for Hodgkin’s lymphoma
BackgroundHodgkin’s lymphoma (HL) is a hematological malignancy that affects both children and young adults. Traditional treatment is associated with...
-
Bilateral mydriasis as first manifestation of Hodgkin’s lymphoma: a case report
BackgroundBilateral mydriasis is usually associated with severe brain stem damage or drug-induced sympathomimetic stimulation.
Herein we report it as...
-
Renomegaly and acute kidney injury as primary manifestations of non-Hodgkin’s lymphoma: a report of three cases
BackgroundIn adults with non-Hodgkin's lymphoma, renal enlargement and acute kidney injury occur infrequently at first presentation, especially in T...
-
Left main and three vessels spontaneous coronary artery dissection as an incidental finding in young man with history of Hodgkin’s lymphoma-a case report
BackgroundSpontaneous coronary artery dissection is a rare and important cause of myocardial infarction, especially in young women without other...
-
The association between primary Sjogren’s syndrome and non-Hodgkin’s lymphoma: a systematic review and meta-analysis of cohort studies
Primary Sjögren’s syndrome (pSS), a chronic autoimmune condition, has been associated with an increased risk of several cancers. This study aims to...
-
Chemotherapy alone vs. chemotherapy plus radiotherapy in female adolescent and young adults with Hodgkin’s lymphoma: reproductive health outcomes
PurposeTo examine the effects of Hodgkin’s lymphoma and its treatment on reproductive health in female adolescent and young adults (AYA).
...
-
Perioperative management of acquired TEF repair in a child with Hodgkin’s lymphoma: a case report
BackgroundAcquired tracheoesophageal fistula (TEF) is a rare presentation in pediatric lymphoma patients. Most heal spontaneously following...
-
Childhood leukemia and non-Hodgkin’s lymphoma survivors lack knowledge about their past disease and possible late effects. I-BFM ELTEC study with Chilean and Croatian participation
PurposeLate effects in childhood cancer survivors are a major cause of morbidity and mortality. The objective was to establish knowledge about the...
-
Ten-year atherosclerotic cardiovascular disease risk trajectories among women veteran cancer patients
Despite a higher risk of cardiovascular disease (CVD) events in women cancer survivors than their male counterparts, importance of female sex has...
-
A real-world analysis of PD1 blockade from the Rete Ematologica Pugliese (REP) in patients with relapse/refractory Hodgkin’s lymphoma
Checkpoint inhibitors have significantly changed the prognosis of patients with relapsing refractory classical Hodgkin’s lymphoma (cHL),...
-
Evaluation of the cachexia index using a bioelectrical impedance analysis in elderly patients with non-Hodgkin’s lymphoma: A single-center prospective study
Cancer cachexia is a disorder that affects patient outcomes. The present study prospectively evaluated the prognostic value of the cachexia index...
-
A Case of Medullary Carcinoma of Colon Morphologically Resembling Non-Hodgkin’s Lymphoma
Medullary carcinoma of the colon is an unusual and unique histologic subtype of colorectal cancer. It is strongly associated with microsatellite...
-
Patterns of PET-positive residual tissue at interim restaging and risk of treatment failure in advanced-stage Hodgkin’s lymphoma: an analysis of the randomized phase III HD18 trial by the German Hodgkin Study Group
PurposeResponse-adapted treatment using early interim functional imaging with PET after two cycles of chemotherapy (PET-2) for advanced-stage...
-
Autoimmune hemolytic anemia in patients with relapsed Hodgkin’s lymphoma after treatment with penpulimab, a monoclonal antibody against programmed death receptor-1
In August 2021, penpulimab, an anti-programmed cell death 1 (PD-1) monoclonal antibody, was approved in China for the treatment of adult patients...
-
The role of interleukins and the widely studied TNF-α in non-Hodgkin’s lymphoma
Non-Hodgkin’s lymphoma is a relatively common cancer with malignant tendencies. Although there is no current cure for the disease, research has been...
-
Safety and Effectiveness of Rasburicase in the Control of Hyperuricemia in Pediatric Patients with Non-Hodgkin’s Lymphoma and Acute Leukemia: An Open-Label, Single-Arm, Multi-center, Interventional Study
IntroductionDespite rasburicase's proven efficiency in Caucasians, Japanese, and Koreans, studies evaluating the safety and effectiveness of...
-
Clinicopathologic features and therapy outcome in childhood Hodgkin’s lymphoma: a report from tertiary care center in Saudi Arabia
BackgroundHodgkin lymphoma (HL) is lymphoid neoplasm usually affecting lymphatic system; it accounts 3.6% of cancers in Saudi Arabia. Modern...
